The company has three main products, 70% of which are called "Avery" (full name "modified sodium hyaluronate gel for injection"). Open a micro plastic surgery APP and search for "Avery" to display the price as 1280 yuan /ml. However, as can be seen in the corporate announcement, the average selling price of this product is 368 yuan/piece. According to the purchase price of 20 16, the raw material cost includes sodium hyaluronate 159.82 yuan /g, prefilled syringe 8.8 yuan/piece, disposable sterile injection needle 4.76 yuan/piece, and the total cost is 173.38 yuan.
In other words, the average ex-factory price of this product is twice the cost of raw materials, but it has increased more than seven times when it is sold to consumers. As can be seen in the announcement, the gross profit margin of "Aifulai" reached 85.86%. Even so, it is still the lowest gross profit margin among the three products of Aimeike Company. "Aifulai" belongs to painless hyaluronic acid and is injected into nasolabial groove. The remaining two products are Yimei and Bonida, which are used for forehead and nasolabial groove injection. The average price is 93 1 yuan and 2530 yuan respectively. Take Bonida as an example, its price on a micro-plastic APP is 9800 yuan //0.5ML, and the announcement shows that Bonida's gross profit margin has reached 98.23%.
On 20 16, Aimeike * * sold 307,300 pieces of hyaluronic acid. The low-end brand Aifulai has the largest sales volume of 276,400 pieces; Bonida has the lowest sales volume, with 5,300 pieces. The company's gross profit margin is as high as 90%. Aimeike specializes in research and development, production and sales of biomedical materials. Self-developed products are mainly aimed at the repair of wrinkled skin of face and neck, belonging to Class III medical devices, which are supervised by China Food and Drug Administration.